The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.
Open accessAbstract
It is postulated that vascular disease involves a disturbance in the homeostatic balance of factors regulating vascular tone and structure. Recent developments in gene transfer techniques have emerged as an exciting therapeutic option to treat vascular disease. Several studies have established the feasibility of direct in vivo gene transfer into the vasculature by using reporter genes such as beta-galactosidase or luciferase. To date no study has documented therapeutic effects with in vivo gene transfer of a cDNA encoding a functional enzyme. This study tests the hypothesis that endothelium-derived nitric oxide is an endogenous inhibitor of vascular lesion formation. After denudation by balloon injury of the endothelium of rat carotid arteries, we restored endothelial cell nitric oxide synthase (ec-NOS) expression in the vessel wall by using the highly efficient Sendai virus/liposome in vivo gene transfer technique. ec-NOS gene transfection not only restored NO production to levels seen in normal untreated vessels but also increased vascular reactivity of the injured vessels. Neointima formation at day 14 after balloon injury was inhibited by 70%. These findings provide direct evidence that NO is an endogenous inhibitor of vascular lesion formation in vivo (by inhibiting smooth muscle cell proliferation and migration) and suggest the possibility of ec-NOS transfection as a potential therapeutic approach to treat neointimal hyperplasia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Efficient selection for high-expression transfectants with a novel eukaryotic vector
Hitoshi, N., Ken-ichi, Y., & Jun-ichi, M. (1991) · Gene · doi:10.1016/0378-1119(91)90434-d · Cited by 5,134
Garg, U. C., & Hassid, A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114081 · Cited by 2,155
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,889
Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues.
Dawson, T. M., Bredt, D. S., Fotuhi, M., Hwang, P. M., & Snyder, S. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7797 · Cited by 1,843
Clowes, A. W., Reidy, M. A., & Clowes, M. M. (1983) · PubMed · Cited by 1,437
An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.
Radomski, M. W., Palmer, R. M., & Moncada, S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5193 · Cited by 1,208
Inhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGF
Ferns, G. A. A., Raines, E. W., Sprugel, K. H., Motani, A. S., Reidy, M. A., & Ross, R. (1991) · Science · doi:10.1126/science.1653454 · Cited by 1,065
Lamas, S., Marsden, P. A., Li, G. K., Tempst, P., & Michel, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6348 · Cited by 982
Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
Simons, M., Edelman, E. R., DeKeyser, J.-L., Langer, R., & Rosenberg, R. D. (1992) · Nature · doi:10.1038/359067a0 · Cited by 731
Cited by
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., Sessa, W. C., & Walsh, K. (2000) · Nature Medicine · doi:10.1038/79510 · Cited by 1,439
Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181
Self-citationNitric oxide synthases: which, where, how, and why?
Michel, T., & Feron, O. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119750 · Cited by 1,011
Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
Dzau, V. J., Braun-Dullaeus, R. C., & Sedding, D. G. (2002) · Nature Medicine · doi:10.1038/nm1102-1249 · Cited by 831
Self-citationDirect evidence for the importance of endothelium-derived nitric oxide in vascular remodeling.
Rudic, R. D., Shesely, E. G., Maeda, N., Smithies, O., Segal, S. S., & Sessa, W. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1699 · Cited by 821
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Félétou, M., & Vanhoutte, P. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00292.2006 · Cited by 818
Evgenov, O. V., Pacher, P., Schmidt, P. M., Haskó, G., Schmidt, H. H. H. W., & Stasch, J.-P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2038 · Cited by 749
NITRIC OXIDE SYNTHASE: Role in the Genesis of Vascular Disease
Cooke, M., & Dzau, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.489 · Cited by 710
Endothelial Dysfunction: Does It Matter? Is It Reversible?
Celermajer, D. S. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00189-7 · Cited by 681
Cardiac Allograft Vasculopathy: Recent Developments
Schmauss, D., & Weis, M. (2008) · Circulation · doi:10.1161/circulationaha.107.711911 · Cited by 587
Does ADMA Cause Endothelial Dysfunction?
Cooke, J. P. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2032 · Cited by 581
Self-citationMolecular Basis of Restenosis and Drug-Eluting Stents
Costa, M. A., & Simon, D. I. (2005) · Circulation · doi:10.1161/01.cir.0000163587.36485.a7 · Cited by 510
Caulin-Glaser, T., García-Cardeña, G., Sarrel, P., Sessa, W. C., & Bender, J. R. (1997) · Circulation Research · doi:10.1161/01.res.81.5.885 · Cited by 473
Local Delivery of Plasmid DNA Into Rat Carotid Artery Using Ultrasound
Taniyama, Y., Tachibana, K., Hiraoka, K., Namba, T., Yamasaki, K., Hashiya, N., Aoki, M., Ogihara, T., Yasufumi, K., & Morishita, R. (2002) · Circulation · doi:10.1161/hc1002.105228 · Cited by 470
Self-citationRegulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Iβ
Schlossmann, J., Ammendola, A., Ashman, K., Zong, X., Huber, A., Neubauer, G., Wang, G.-X., Allescher, H.-D., Korth, M., Wilm, M., et al. (2000) · Nature · doi:10.1038/35004606 · Cited by 456
Griese, D. P., Ehsan, A., Melo, L. G., Kong, D., Zhang, L., Mann, M. J., Pratt, R. E., Mulligan, R. C., & Dzau, V. J. (2003) · Circulation · doi:10.1161/01.cir.0000096490.16596.a6 · Cited by 441
Self-citationCardiac Allograft Vasculopathy: A Review
Weis, M., & von Scheidt, W. (1997) · Circulation · doi:10.1161/01.cir.96.6.2069 · Cited by 433
Nitric Oxide Reversibly Inhibits the Migration of Cultured Vascular Smooth Muscle Cells
Sarkar, R., Meinberg, E. G., Stanley, J. C., Gordon, D., & Clinton Webb, R. (1996) · Circulation Research · doi:10.1161/01.res.78.2.225 · Cited by 421
Sorescu, D., & Griendling, K. K. (2002) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2002.00717.x · Cited by 406
van der Zee, R., Murohara, T., Luo, Z., Zollmann, F., Passeri, J., Lekutat, C., & Isner, J. M. (1997) · Circulation · doi:10.1161/01.cir.95.4.1030 · Cited by 403
Asymmetrical Dimethylarginine: The Über Marker?
Cooke, J. P. (2004) · Circulation · doi:10.1161/01.cir.0000126823.07732.d5 · Cited by 396
Self-citationROLE OF ENDOTHELIUM IN THROMBOSIS AND HEMOSTASIS
Wu, M. D., & Thiagarajan, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.315 · Cited by 384
Endothelium-derived microparticles impair endothelial function in vitro
Brodsky, S. V., Zhang, F., Nasjletti, A., & Goligorsky, M. S. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01172.2003 · Cited by 379
Ylä-Herttuala, S., & Martin, J. F. (2000) · The Lancet · doi:10.1016/s0140-6736(99)04180-x · Cited by 375
Biomarkers of renal function, which and when?
Wasung, M. E., Chawla, L. S., & Madero, M. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.039 · Cited by 374
Allograft Vasculopathy Versus Atherosclerosis
Rahmani, M., Cruz, R. P., Granville, D. J., & McManus, B. M. (2006) · Circulation Research · doi:10.1161/01.res.0000246086.93555.f3 · Cited by 347
Apoptosis in the vasculature: mechanisms and functional importance
Mallat, Z., & Tedgui, A. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703407 · Cited by 343
Pollman, M. J., Yamada, T., Horiuchi, M., & Gibbons, G. H. (1996) · Circulation Research · doi:10.1161/01.res.79.4.748 · Cited by 341
Self-citationDayoub, H., Achan, V., Adimoolam, S., Jacobi, J., Stuehlinger, M. C., Wang, B.-Y., Tsao, P. S., Kimoto, M., Vallance, P., Patterson, A. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000101924.04515.2e · Cited by 340
Self-citationDulak, J., Józkowicz, A., Dembinska-Kiec, A., Guevara, I., Zdzienicka, A., Zmudzinska-Grochot, D., Florek, I., Wójtowicz, A., Szuba, A., & Cooke, J. P. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.3.659 · Cited by 329
Self-citationTakemoto, M., Egashira, K., Usui, M., Numaguchi, K., Tomita, H., Tsutsui, H., Shimokawa, H., Sueishi, K., & Takeshita, A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119156 · Cited by 325
Darley-Usmar, V., & Halliwell, B. (1996) · Pharmaceutical Research · doi:10.1023/a:1016079012214 · Cited by 313
Local drug and gene delivery through microbubbles
Unger, E. C., Hersh, E., Vannan, M., Matsunaga, T. O., & McCreery, T. (2001) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2001.26443 · Cited by 307
Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells
Brodsky, S. V., Yamamoto, T., Tada, T., Kim, B., Chen, J., Kajiya, F., & Goligorsky, M. S. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00329.2001 · Cited by 303
Endothelial Dysfunction Induced by Hyperhomocyst(e)inemia: Role of Asymmetric Dimethylarginine
Stühlinger, M. C., Oka, R. K., Graf, E. E., Schmölzer, I., Upson, B. M., Kapoor, O., Szuba, A., Malinow, M. R., Wascher, T. C., Pachinger, O., et al. (2003) · Circulation · doi:10.1161/01.cir.0000085067.55901.89 · Cited by 303
Self-citationSignaling mechanisms mediating vascular protective actions of vascular endothelial growth factor
Zachary, I. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.6.c1375 · Cited by 301
Enhanced Inhibition of Neointimal Hyperplasia by Genetically Engineered Endothelial Progenitor Cells
Kong, D., Melo, L. G., Mangi, A. A., Zhang, L., Lopez-Ilasaca, M., Perrella, M. A., Liew, C. C., Pratt, R. E., & Dzau, V. J. (2004) · Circulation · doi:10.1161/01.cir.0000121732.85572.6f · Cited by 288
Self-citationNitric oxide and the proliferation of vascular smooth muscle cells
Jeremy, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00171-6 · Cited by 285
Cell Cycle Progression: New Therapeutic Target for Vascular Proliferative Disease
Braun-Dullaeus, R. C., Mann, M. J., & Dzau, V. J. (1998) · Circulation · doi:10.1161/01.cir.98.1.82 · Cited by 285
Self-citationOhashi, Y., Kawashima, S., Hirata, K. I., Yamashita, T., Ishida, T., Inoue, N., Sakoda, T., Kurihara, H., Yazaki, Y., & Yokoyama, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4394 · Cited by 277
Maulik, N., & Das, D. K. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01005-5 · Cited by 267
Nitric Oxide Synthases and Cardiac Muscle: Autocrine and Paracrine Influences
Balligand, J.-L., & Cannon, P. J. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.1846 · Cited by 260
Nitric Oxide-Releasing Polymers Containing the [N(O)NO]-Group
Smith, D. J., Chakravarthy, D., Pulfer, S., Simmons, M. L., Hrabie, J. A., Citro, M. L., Saavedra, J. E., Davies, K. M., Hutsell, T. C., Mooradian, D. L., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950652b · Cited by 208
The use of thiols by ribonucleotide reductase
Holmgren, A., & Sengupta, R. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.005 · Cited by 116
Alef, M. J., Vallabhaneni, R., Carchman, E., Morris, S. M., Shiva, S., Wang, Y., Kelley, E. E., Tarpey, M. M., Gladwin, M. T., Tzeng, E., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44079 · Cited by 101
“NO has been shown to have many vasoprotective properties, which has led to investigation into NO-based therapies to prevent vaso-occlusive complications of vascular injury (44, 45).”
BackgroundVasculoprotective Roles of Neuronal Nitric Oxide Synthase
Morishita, T., Tsutsui, M., Shimokawa, H., Horiuchi, M., Tanimoto, A., Suda, O., Tasaki, H., Huang, P. L., Sasaguri, Y., Yanagihara, N., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0155fje · Cited by 94
“This notion is supported by the fact that eNOS-knockout (eNOS-KO) mice exhibit accelerated neointimal formation (5, 6) and abnormal vascular remodeling (7) and that eNOS gene overexpression in transgenic mice (8) or by gene transfer (9) suppresses vascular lesion formation.”
BackgroundNitric Oxide: Implications for Vascular and Endovascular Surgery
Vural, K. M., & Bayazit, M. (2001) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.2001.1448 · Cited by 43
Nitric oxide and nitrite-based therapeutic opportunities in intimal hyperplasia
Alef, M. J., Tzeng, E., & Zuckerbraun, B. S. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.03.014 · Cited by 20
Metadata
- Authors
- von der Leyen, H. E., Gibbons, G. H., Morishita, R., Lewis, N. P., Zhang, L., Nakajima, M., Kaneda, Y., Cooke, J. P., & Dzau, V. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-02-14
- Volume
- 92
- Issue
- 4
- Pages
- 1137-1141
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2111787291
- Cited by
- 762
- References
- 23
- FWCI
- 47.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.